In the BioHarmony Drug Report Database

"Preview" Icon

Caffeine citrate

Cafcit, Nymusa, Peyona (caffeine, citrated) is a small molecule pharmaceutical. Caffeine, citrated was first approved as Cafcit on 1999-09-21. It has been approved in Europe to treat apnea. The pharmaceutical is active against adenosine receptor A2a, adenosine receptor A3, adenosine receptor A2b, and adenosine receptor A1.

 

Trade Name

 

Nymusa, Peyona
 

Common Name

 

caffeine, citrated
 

ChEMBL ID

 

CHEMBL1200569
 

Indication

 

apnea
 

Drug Class

 

Image (chem structure or protein)

Caffeine citrate structure rendering